NEXT-GEN BIOACTIVES

Clinical studies show MELAVOID® reduces tyrosinase enzyme levels by 63% compared to the control, helping to decrease melanin production.

Clinical results show Acxosome®-CICA increases Hyaluronan Synthase 3 (HAS3) expression by 4×, enhancing the skin’s hyaluronic acid production.

Clinical studies show Derma-Clera® enhances skin recovery, improving anti-irritation effects by up to 63.1%, outperforming conventional agents and supporting skin barrier repair.

Clinical studies shows Dendriclear® balances acneic and non-acneic strains, boosting the skin's natural defense.

Clinical studies shows that 98–100% of sensitive adults and babies showed no adverse reactions, confirming excellent skin compatibility.

Clinical studies shows that Oligopeptide-1 eliminates harmful free radicals like hydroxyl and peroxyl that cause oxidative stress.

46% Increase in Epidermal Thickness and Visible Wrinkle Reduction

 

Users reported enhanced skin protection and reduced sensitivity to UV exposure after using Raybloc®

Clinical trials show Skinveria™ delivers persistent moisturization for up to 48 hours after a single application

Reduces UV-induced damage by 55.7%, minimizing sunburn cells, oxidative stress, and photoaging.

Clinical studies showed oil skin levels significantly decreased after just 2 weeks of application.

Clinical study showed users noticed their skin felt more moisturized and appeared healthier after 28 days.

Clinical study shows 5% niacinamide shows significant improvement in fine lines and wrinkles after 8 and 12 weeks.

A clinical study showed that a cream with 5% HyaMatrix™ VII+ increased skin moisture within 5 minutes of application.